ACR Convergence 2024—In a wide-ranging and engaging discussion, members of the Association of Rheumatology Professionals (ARP) tracked their progress over the years across clinical practice, research production and representation in the field, while outlining challenges and opportunities to come. The session at ACR Convergence included a panel and an audience full of past presidents of…
WASHINGTON, D.C.—It is no small task to summarize an entire year’s worth of research accomplishments in any field of medicine, let alone one as complex as rheumatology. At ACR Convergence 2024, the Pediatric Year in Review not only provided a thoughtful summary, but also grouped advances along several different themes. Immune Health & More Jessica…
“What we’re after here is something called active allyship,” said Dr. Dwinita Mosby Tyler, CEO and founder of The Equity Project in her keynote address at ACR Convergence 2024. “It’s where you witness something that might be an injustice or you might see a disparity, and you don’t just talk about it, you research it; you do something about it.”
Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is a rare autoimmune condition characterized by inflammation of small- and medium-sized vessels. ANCA-associated vasculitis can lead to multisystem organ complications, including life-threatening pulmonary hemorrhage, renal failure and death. We present a case of ANCA-associated vasculitis complicated by complement-mediated thrombotic microangiopathy (c-TMA). Of the rheumatic diseases, systemic lupus erythematosus…
The advent of biosimilar medications has offered the promise of significant cost savings for healthcare systems and patients. Biosimilars are highly similar versions of existing biologic drugs, providing a more affordable alternative once the original biologic patent expires. However, the adoption of biosimilars in the U.S. has been hampered by myriad roadblocks, many of which…
As rheumatology fellows around the country begin to explore various career opportunities, they typically look to academic rheumatology, private practice, industry and research. Vivek K. Murthy, MD, MSc, however, has carved a unique clinical pathway in both rheumatology and hospital medicine, merging his various skills and interests in medical education, diagnostic expertise and clinical problem…
Welcome to the first edition of the President’s Corner! I am grateful to Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS, and the editors of The Rheumatologist for their support and encouragement in allowing me to have this opportunity each month to come together with rheumatologists and rheumatology health professionals. So why the President’s Corner? In…
It’s dark. It’s cold. And it’s 5 p.m. here in Iowa. If that sounds rather bleak to you, I wouldn’t blame you. But to Stella, my 12-year-old canine companion, it’s a wonderland. She’s half-Shetland sheepdog and half-American Eskimo, so the colder and snowier it is, the more she feels at home. And although I do…
WASHINGTON, D.C.—For the first time in U.S. history, older adults are projected to outnumber children by 2034, and their care poses unique challenges to the rheumatologist.1 Normal physiologic changes of aging include but aren’t limited to falling renal function, changes in pharmacokinetics and bone density loss. At the ACR Convergence 2024 Review Course, Namrata Singh,…
Dr. Jonas has long sought bold and innovative approaches to workforce challenges in rheumatology. As new chair of the Workforce Solutions Committee, she aims to increase the role of advanced practice providers in rheumatology practices and reduce wait times for specialty care.